Concepedia

Edikan Archibong

EA

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

2014

Affiliations

University of North Carolina at Chapel Hill(Current)

University of South Florida

North Carolina State University

Soochow University

California NanoSystems Institute

Edikan Archibong is an author at University of North Carolina at Chapel Hill specializing in cancer immunotherapy, oncology, and hemolytic disorders.

Publications per year

2014–2021

8

Publications

8

Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets

Quanyin Hu, Hongjun Li, Edikan Archibong et al. · Nature Biomedical Engineering · 2021 · 371 citations · Full text

Medicine, Oncology, Surgery +15

Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy

Xiao Han, Shufang Shen, Qin Fan et al. · Science Advances · 2019 · 340 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Synthetic beta cells for fusion-mediated dynamic insulin secretion

Zhaowei Chen, Jinqiang Wang, Wujin Sun et al. · Nature Chemical Biology · 2017 · 255 citations

Life Sciences, Cell Biology, Endocrinology +14

In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence

Xiao Han, Rui Wang, Jun Xu et al. · Biomaterials · 2019 · 92 citations

Medicine, Immunology, Oncology +16

A mobile phone-based approach to detection of hemolysis

Edikan Archibong, Karthik Raj Konnaiyan, Howard Kaplan et al. · Biosensors and Bioelectronics · 2016 · 29 citations

Engineering, Bioengineering, Biomedical Engineering +5

1–5 of 8